---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-001324"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T04:50:20.176152+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp. Q4 revenue $22.4M (+32% YoY); net income $224K; guides FY22 rev $102-106M

## Summary
- Full-year 2021 revenue $81.2M (+38% YoY); system-wide sales $361.1M (+39%).
- Net income $7.2M for 2021 vs. $13.2M in 2020; Adjusted EBITDA $13.3M vs. $9.1M.
- Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total 706 clinics at year-end.
- Q4 net income $224K ($0.01 diluted EPS) vs. $10.6M ($0.72) in Q4 2020, which included $8.9M tax benefit.
- Guides 2022 revenue $102-106M, Adjusted EBITDA $15-17M, and 160-180 total new clinics.

## SEC filing metadata
- accession: 0001171843-22-001324
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/0001171843-22-001324-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/f8k_022422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-001324
- JSON: https://secwatch.observer/filing/0001171843-22-001324.json
- Plain text: https://secwatch.observer/filing/0001171843-22-001324.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.